The epidemiology of Porphyromonas asaccharolytica needs to be better studied. Still, it is known to be a rare cause of Lemierre’s syndrome, a severe condition that affects young adults and can lead to septic emboli and organ failure. Infections like bacteremia, endocarditis, abscesses, and periodontitis are also linked to Porphyromonas asaccharolytica. The oral flora typically contains Porphyromonas asaccharolytica, however when the mucosal barrier is compromised or the host immune system is weakened, it can turn pathogenic.

The transmission of Porphyromonas asaccharolytica is unclear, but it may occur through direct contact with oral secretions or blood from infected individuals. The prevalence of Porphyromonas asaccharolytica in different populations and regions is unknown, but it may vary depending on the hosts’ oral hygiene, dietary habits, and genetic factors.

A type of anaerobic bacterium called Porphyromonas asaccharolytica can be isolated and recognized from blood cultures or additional samples using biochemical assays or molecular techniques. Treating Porphyromonas asaccharolytica infection usually involves a combination of antibiotics effective against anaerobes, such as metronidazole, clindamycin, or ampicillin-sulbactam. Additionally, anticoagulation therapy may be required for patients with thrombophlebitis. A rare but potentially fatal illness called Porphyromonas asaccharolytica infection necessitates rapid diagnosis and treatment.

• Kingdom: Bacteria
• Phylum: Bacteroidetes
• Class: Bacteroidia
• Order: Bacteroidales
• Family: Porphyromonadaceae
• Genus: Porphyromonas
• Species: P. asaccharolytica
• The structure of Porphyromonas asaccharolytica is the following:
• Porphyromonas asaccharolytica is a gram-negative, anaerobic bacterium that belongs to the genus Porphyromonas and the family Porphyromonadaceae.
• Porphyromonas asaccharolytica is a rod-shaped bacterium that is not mobile and does not produce spores.
• Porphyromonas asaccharolytica has a lipopolysaccharide (LPS)–containing outer membrane, which consists of three regions: lipid A, core oligosaccharide, and O-antigen.
• The O-antigen is the most variable part of the LPS and determines the serotype of the bacterium. There are at least two serotypes of  Porphyromonas asaccharolytica based on the O-antigen structure: serotype I and serotype II (or serotype A and serotype B).
• Porphyromonas asaccharolytica requires heme or hemin and vitamin K for growth, producing black pigment when grown on blood agar.

• The antigenic types of Porphyromonas asaccharolytica need to be well documented. Still, some studies have suggested that there are at least two serotypes based on the bacterium’s lipopolysaccharide (LPS) structure. LPS is a component of the outer membrane of gram-negative bacteria that can elicit an immune response in the host. The LPS of Porphyromonas asaccharolytica consists of three regions: lipid A, core oligosaccharide, and O-antigen. The O-antigen is the most variable part of the LPS and determines the serotype of the bacterium. The O-antigen of Porphyromonas asaccharolytica is composed of repeating units of sugars, such as glucose, galactose, rhamnose, and N-acetylglucosamine.
• One study reported two serotypes of Porphyromonas asaccharolytica based on the O-antigen structure: serotype I and serotype II. Serotype I have a tetrasaccharide repeating unit with the following structure: ->4)-alpha-D-Glcp-(1->4)-beta-D-Galp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpNAc-(1->. Serotype II has a pentasaccharide repeating unit with the following structure: ->4)-alpha-D-Glcp-(1->4)-beta-D-Galp-(1->3)-alpha-L-Rhap-(1->2)-alpha-D-Glcp-(1->3)-beta-D-GlcpNAc-(1->. The study also found that serotype I was more prevalent than serotype II among clinical isolates of Porphyromonas asaccharolytica.
• The two studies used different methods to analyze the O-antigen structure of Porphyromonas asaccharolytica, such as gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) spectroscopy. Therefore, they identified the same or similar serotypes with different terminology. Further studies are needed to confirm the antigenic types and prevalence of Porphyromonas asaccharolytica in different populations and regions.

• The pathogenesis of Porphyromonas asaccharolytica in Lemierre’s syndrome is not fully understood, but some possible mechanisms have been proposed. One mechanism is that Porphyromonas asaccharolytica produces extracellular toxins that are virulent and heat-labile. These toxins may damage the mucosal epithelium and activate the inflammatory response in the oropharynx. The toxins may also facilitate the invasion of the bacterium into the bloodstream and the internal jugular vein. Another mechanism is that Porphyromonas asaccharolytica has collagenase and trypsin-like activities that can degrade the blood vessels’ extracellular matrix and basement membrane. It may allow the bacterium to penetrate the vascular wall and cause thrombophlebitis. A third mechanism is that Porphyromonas asaccharolytica has lipopolysaccharide (LPS) on its outer membrane that can elicit an immune response in the host. The LPS of Porphyromonas asaccharolytica consists of three regions: lipid A, core oligosaccharide, and O-antigen. The O-antigen is the most variable part of the LPS and determines the serotype of the bacterium. The O-antigen of Porphyromonas asaccharolytica may trigger the production of antibodies that cross-react with host tissues and cause tissue damage.
• The pathogenesis of  Porphyromonas asaccharolytica in Lemierre’s syndrome leads to severe complications, such as septic emboli, to various organs, especially the lungs. Septic emboli can cause pulmonary abscesses, pleural effusions, pneumothorax, empyema, and respiratory failure. Other organs that can be affected by septic emboli are the brain, liver, spleen, kidneys, bones, joints, and skin.

• The host defenses against Porphyromonas asaccharolytica are not well understood, but some studies have suggested some possible mechanisms:
• The oral mucosa and saliva provide a physical and chemical barrier that prevents the attachment and invasion of Porphyromonas asaccharolytica. Saliva contains antimicrobial substances, such as lysozyme, lactoferrin, immunoglobulin A (IgA), and histatins, that can inhibit the growth and activity of Porphyromonas asaccharolytica.
• Porphyromonas asaccharolytica is recognised by the innate immune system via pattern recognition receptors (PRRs), such as tolling-like receptors (TLRs) including nucleotide-binding oligomerization domain (NOD) -like receptors (NLRs), that bind to pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) and peptidoglycan, on the bacterial surface. It triggers the activation of inflammatory pathways, such as nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK), that lead to the production of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ), that recruit and activate phagocytic cells, such as neutrophils and macrophages, that can engulf and kill Porphyromonas asaccharolytica.
• The adaptive immune system generates a specific response to Porphyromonas asaccharolytica by activating B and T cells. B cells produce antibodies, such as IgG and IgM, that can bind to Porphyromonas asaccharolytica and mark it for opsonization and complement-mediated lysis. T cells produce cytokines, such as IL-2, IL-4, IL-10, IL-17, IFN-γ, and TNF-α, that can modulate the inflammatory response and enhance the killing of Porphyromonas asaccharolytica by phagocytic cells.

• It is one of the rare causes of Lemierre’s syndrome, a severe condition characterized by an oropharyngeal infection, followed by internal jugular vein thrombophlebitis and septic emboli to different organs. Other illnesses caused by Porphyromonas asaccharolytica include endocarditis, bacteremia, periodontitis, and abscesses. Some clinical manifestations of Porphyromonas asaccharolytica infection are fever, chills, sore throat, neck pain, dysphagia, odynophagia, cervical lymphadenopathy, respiratory distress, chest pain, and septic shock.
• The diagnosis of Porphyromonas asaccharolytica infection is based on isolating and identifying the bacterium from blood cultures or other specimens.

• To diagnose Porphyromonas asaccharolytica:
• Culture: Isolate the bacterium from clinical samples and grow it on anaerobic media. Colonies are small, circular, convex, and smooth and may produce a brownish-black pigment.
• Gram Stain: Use a quick stain to visualize the bacterium’s gram-negative, rod-shaped characteristics.
• Biochemical Tests: Conduct tests to detect specific enzymes or metabolic products. Examples include catalase, oxidase, indole, urease, nitrate reduction, esculin hydrolysis, and carbohydrate fermentation.
• Molecular Methods: Employ advanced techniques like PCR, real-time PCR, 16S rRNA gene sequencing, or MALDI-TOF MS to amplify and detect the bacterium’s genetic material for higher sensitivity and specificity. These methods may be costlier and require specialized equipment and expertise.

• The following actions can be done to control Porphyromonas asaccharolytica:
• Oral Hygiene: Brush teeth twice daily, floss daily, use mouthwash, and visit the dentist regularly to remove plaque and reduce gum inflammation.
• Antibiotics: Prescribed by a doctor or dentist for acute or chronic infections. Be cautious due to potential antibiotic resistance.
• Surgery: A last resort for severe cases that don’t respond to hygiene or antibiotics. It may involve tissue removal, abscess drainage, or repair of damaged organs.

• Porphyromonas Asaccharolytica – an overview | ScienceDirect Topics
• Pathogenicity of Porphyromonas asaccharolytica in Adult Periodontitis of Malaysian Samples (scialert.net)